{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:57:34Z","timestamp":1790895454379,"version":"4.1.0"},"reference-count":157,"publisher":"Georg Thieme Verlag KG","issue":"02","funder":[{"name":"Division of Diabetes, Endocrinology, and Metabolic Diseases","award":["R01DK085252, R01DK138591"],"award-info":[{"award-number":["R01DK085252, R01DK138591"]}]},{"name":"National Cancer Institute","award":["P01CA233452, R01CA301632"],"award-info":[{"award-number":["P01CA233452, R01CA301632"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) is increasingly recognized as a driver of metastatic progression in the liver. In addition to its association with hepatocellular carcinoma, the steatotic liver supports metastatic colonization from extrahepatic malignancies by altering hepatic metabolism, stromal organization, vascular architecture, and immune surveillance. Clinical and experimental studies show higher rates of liver metastasis and postoperative recurrence for colorectal, pancreatic, and breast cancers in MASLD. The underlying mechanisms are multifactorial. Hepatocyte lipid overload reshapes lipid metabolism and availability, generating lipotoxic stress signals that support the metabolic adaptation of tumor cells. The steatotic liver also promotes extracellular matrix remodeling, hepatic stellate cell activation, sinusoidal capillarization, and the accumulation of immunosuppressive macrophages and exhausted T cells. Tumor- and liver-derived extracellular vesicles further amplify these changes by transporting lipids, cytokines, and microRNAs that establish a permissive premetastatic niche. Although the contribution of hepatic zonation to metastatic outgrowth is poorly characterized, altered zonation likely enhances metastatic fitness by creating spatial gradients in oxygen tension, lipid metabolism, and immune activity. In conclusion, MASLD can reshape the hepatic metastatic microenvironment, which may lead to metabolic- and immune-targeted therapies to treat liver metastasis in patients with MASLD.<\/jats:p>","DOI":"10.1055\/a-2921-0092","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:27:56Z","timestamp":1785886076000},"page":"156-170","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Dysfunction\u2013Associated Steatotic Liver Disease Reprograms the Hepatic Metastatic Niche"],"prefix":"10.1055","volume":"46","author":[{"given":"Mustafa","family":"Karabicici","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, California, United States","place":["Los Angeles"],"department":["Department of Medicine, Karsh Division of Gastroenterology and Hepatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-6085","authenticated-orcid":false,"given":"Ekihiro","family":"Seki","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, California, United States","place":["Los Angeles"],"department":["Department of Medicine, Karsh Division of Gastroenterology and Hepatology"]},{"name":"Cedars-Sinai Medical Center, California, United States","place":["Los Angeles"],"department":["Department of Biomedical Sciences, Division of Applied Cell Biology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"A Do","year":"2025","journal-title":"Nat Rev Drug Discov"},{"issue":"48","key":"ref2","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.3748\/wjg.v30.i48.5205","article-title":"GLP-1, GIP\/GLP-1, and GCGR\/GLP-1 receptor agonists: novel therapeutic agents for metabolic dysfunction-associated steatohepatitis","volume":"30","author":"A Singh","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"G Targher","year":"2024","journal-title":"Gut"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"e14276","DOI":"10.1111\/eci.14276","article-title":"Association of MASLD with the risk of extrahepatic cancers: a systematic review and meta-analysis of 18 cohort studies","volume":"54","author":"B G Zhou","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"156004","DOI":"10.1016\/j.metabol.2024.156004","article-title":"Metabolic dysfunction-associated steatotic liver disease and its link to cancer","volume":"160","author":"M Kalligeros","year":"2024","journal-title":"Metabolism"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","article-title":"Colorectal liver metastases: current management and future perspectives","volume":"11","author":"J Martin","year":"2020","journal-title":"World J Clin Oncol"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1245\/s10434-013-3297-7","article-title":"Cause of death from liver metastases in colorectal cancer","volume":"21","author":"T S Helling","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/genes11010006","article-title":"Metastasis in pancreatic ductal adenocarcinoma: current standing and methodologies","volume":"11","author":"M Ayres Pereira","year":"2019","journal-title":"Genes (Basel)"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10585-021-10080-4","article-title":"Breast cancer liver metastasis: current and future treatment approaches","volume":"38","author":"N S Rashid","year":"2021","journal-title":"Clin Exp Metastasis"},{"issue":"30","key":"ref10","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.12998\/wjcc.v10.i30.10882","article-title":"Clinical characteristics and prognosis of non-small cell lung cancer patients with liver metastasis: a population-based study","volume":"10","author":"J F Wang","year":"2022","journal-title":"World J Clin Cases"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"631943","DOI":"10.3389\/fonc.2021.631943","article-title":"Hepatic steatosis predicts higher incidence of recurrence in colorectal cancer liver metastasis patients","volume":"11","author":"H Chen","year":"2021","journal-title":"Front Oncol"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","article-title":"Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment","volume":"35","author":"Z Wang","year":"2023","journal-title":"Cell Metab"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"e104934","DOI":"10.1136\/bmjopen-2025-104934","article-title":"Metabolic dysfunction-associated steatotic liver disease and colorectal neoplasms risk: a global propensity score-matched retrospective cohort study","volume":"15","author":"M Aldiabat","year":"2025","journal-title":"BMJ Open"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s12072-025-10870-y","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0-II colorectal cancer","volume":"19","author":"X Qian","year":"2025","journal-title":"Hepatol Int"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/bjs.9057","article-title":"Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases","volume":"100","author":"Z Z Hamady","year":"2013","journal-title":"Br J Surg"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s12029-024-01042-6","article-title":"Non-alcoholic fatty liver disease may be a risk factor for liver metastasis after radical surgery for colorectal cancer: a retrospective study","volume":"55","author":"T Miyata","year":"2024","journal-title":"J Gastrointest Cancer"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.62347\/JHMS4303","article-title":"Hepatic steatosis predicts metachronous liver metastasis in colorectal cancer patients: a nested case-control study and systematic review","volume":"14","author":"S Dai","year":"2024","journal-title":"Am J Cancer Res"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jcsm.12723","article-title":"Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases","volume":"12","author":"D PJ van Dijk","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41392-025-02562-8","article-title":"Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis","volume":"11","author":"Q Yu","year":"2026","journal-title":"Signal Transduct Target Ther"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-024-07578-2","article-title":"Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4\/6 inhibitor","volume":"210","author":"D Malon","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-017-4411-5","article-title":"Fatty liver decreases the risk of liver metastasis in patients with breast cancer: a two-center cohort study","volume":"166","author":"W Wu","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/1535-7163.MCT-23-0726","article-title":"Inflammation and immunity in liver neoplasms: implications for future therapeutic strategies","volume":"24","author":"J Kim","year":"2025","journal-title":"Mol Cancer Ther"},{"issue":"08","key":"ref24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tem.2024.02.017","article-title":"Unveiling the cancer risk nexus of the steatotic liver","volume":"35","author":"J Kim","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10686-2","article-title":"Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC","author":"Y Peng-Winkler","year":"2026","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fonc.2020.00251","article-title":"Effect of non-alcoholic fatty liver disease on the risk of synchronous liver metastasis: analysis of 451 consecutive patients of newly diagnosed colorectal cancer","volume":"10","author":"Y Lv","year":"2020","journal-title":"Front Oncol"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/iep.12371","article-title":"Fatty change of the liver microenvironment influences the metastatic potential of colorectal cancer","volume":"101","author":"S Masaki","year":"2020","journal-title":"Int J Exp Pathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"101222","DOI":"10.1016\/j.neo.2025.101222","article-title":"Steatohepatitis alters lymphocytes cytotoxicity and localization, accelerating colorectal liver metastases","volume":"69","author":"A S Yehezkel","year":"2025","journal-title":"Neoplasia"},{"key":"ref29","first-page":"5665964","article-title":"Diet-induced obesity promotes liver metastasis of pancreatic ductal adenocarcinoma via CX3CL1\/CX3CR1 axis","volume":"2022","author":"Y Sun","year":"2022","journal-title":"J Immunol Res"},{"issue":"17","key":"ref30","first-page":"5","article-title":"Hepatic lipids promote liver metastasis","volume":"5","author":"Y Li","year":"2020","journal-title":"JCI Insight"},{"issue":"07","key":"ref31","first-page":"135","article-title":"Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment","volume":"135","author":"Y M Yang","year":"2025","journal-title":"J Clin Invest"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"B Costa-Silva","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"7964","key":"ref33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06114-4","article-title":"Tumour extracellular vesicles and particles induce liver metabolic dysfunction","volume":"618","author":"G Wang","year":"2023","journal-title":"Nature"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1136\/gutjnl-2025-334851","article-title":"Extracellular vesicle-induced lipid dysregulation drives liver premetastatic niche formation in colorectal cancer","volume":"74","author":"J Cao","year":"2025","journal-title":"Gut"},{"issue":"S 01","key":"ref35","first-page":"S10","article-title":"Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity","volume":"59","author":"S K Bansal","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"N L Gluchowski","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"ref37","first-page":"101185","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"F Carli","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"N E Sunny","year":"2011","journal-title":"Cell Metab"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2016.11.033","article-title":"VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis","volume":"388","author":"C W Lu","year":"2017","journal-title":"Cancer Lett"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"101624","DOI":"10.1016\/j.mcp.2020.101624","article-title":"Expression level of VLDL receptor and VLDL-c levels in the malignant and benign breast tumors: the correlation with miRNA-4465 and miRNA-1297","volume":"53","author":"A Mosapour","year":"2020","journal-title":"Mol Cell Probes"},{"issue":"09","key":"ref41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41419-023-06161-9","article-title":"The oleic\/palmitic acid imbalance in exosomes isolated from NAFLD patients induces necroptosis of liver cells via the elongase-6\/RIP-1 pathway","volume":"14","author":"M P Scavo","year":"2023","journal-title":"Cell Death Dis"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s43032-020-00223-5","article-title":"Oleic acid counters impaired blastocyst development induced by palmitic acid during mouse preimplantation development: understanding obesity-related declines in fertility","volume":"27","author":"M D Yousif","year":"2020","journal-title":"Reprod Sci"},{"issue":"06","key":"ref43","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"L L Listenberger","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"06","key":"ref44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.trecan.2023.03.003","article-title":"Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis","volume":"9","author":"U Sen","year":"2023","journal-title":"Trends Cancer"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41419-023-05756-6","article-title":"Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance","volume":"14","author":"T Wu","year":"2023","journal-title":"Cell Death Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"102006","DOI":"10.1016\/j.redox.2021.102006","article-title":"Tumor resistance to ferroptosis driven by stearoyl-CoA desaturase-1 (SCD1) in cancer cells and fatty acid binding protein-4 (FABP4) in tumor microenvironment promote tumor recurrence","volume":"43","author":"G Luis","year":"2021","journal-title":"Redox Biol"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-018-0711-9","article-title":"Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN","volume":"37","author":"H Ran","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"101807","DOI":"10.1016\/j.redox.2020.101807","article-title":"FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells","volume":"38","author":"Z Ye","year":"2021","journal-title":"Redox Biol"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-012-2354-4","article-title":"High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients","volume":"137","author":"A M Holder","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"115586","DOI":"10.1016\/j.biopha.2023.115586","article-title":"SCD1 is the critical signaling hub to mediate metabolic diseases: mechanism and the development of its inhibitors","volume":"170","author":"Q Sun","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"e1587","DOI":"10.1002\/ctm2.1587","article-title":"Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1-mediated lipid metabolism","volume":"14","author":"G Che","year":"2024","journal-title":"Clin Transl Med"},{"issue":"24","key":"ref52","first-page":"135","article-title":"Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated \u03b2-catenin activation","volume":"135","author":"C ON Leung","year":"2025","journal-title":"J Clin Invest"},{"issue":"07","key":"ref53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jpha.2023.03.010","article-title":"A Scd1-mediated metabolic alteration participates in liver responses to low-dose bavachin","volume":"13","author":"P Shen","year":"2023","journal-title":"J Pharm Anal"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jare.2024.10.006","article-title":"The fatty acid receptor CD36 promotes macrophage infiltration via p110\u03b3 signaling to stimulate metastasis","volume":"74","author":"H Qin","year":"2025","journal-title":"J Adv Res"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.7150\/ijbs.100794","article-title":"Caveolin-1 mitigates the advancement of metabolic dysfunction-associated steatotic liver disease by reducing endoplasmic reticulum stress and pyroptosis through the restoration of cholesterol homeostasis","volume":"21","author":"H Xu","year":"2025","journal-title":"Int J Biol Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molimm.2025.02.012","article-title":"Caveolin-1 protects against liver injury and lipid accumulation in alcoholic fatty liver via ferroptosis resistance","volume":"181","author":"W Xue","year":"2025","journal-title":"Mol Immunol"},{"issue":"13","key":"ref57","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.7150\/thno.55609","article-title":"Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer","volume":"11","author":"K L Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"46","key":"ref58","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/s41388-018-0384-z","article-title":"CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis","volume":"37","author":"Y N Wang","year":"2018","journal-title":"Oncogene"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41417-021-00348-y","article-title":"Fatty acid \u03b2-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway","volume":"29","author":"F Zeng","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2018.05.112","article-title":"CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling","volume":"106","author":"Y Xiong","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"16441","DOI":"10.1038\/s41598-022-20585-x","article-title":"The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach","volume":"12","author":"M Das","year":"2022","journal-title":"Sci Rep"},{"issue":"32","key":"ref62","doi-asserted-by":"crossref","first-page":"E6556","DOI":"10.1073\/pnas.1703791114","article-title":"CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation","volume":"114","author":"H J Wright","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7239","key":"ref63","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"M Diehn","year":"2009","journal-title":"Nature"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","article-title":"NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism","volume":"23","author":"C L Chen","year":"2016","journal-title":"Cell Metab"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1\u03b1 balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells","volume":"22","author":"P Sancho","year":"2015","journal-title":"Cell Metab"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"T Wang","year":"2018","journal-title":"Cell Metab"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"101589","DOI":"10.1016\/j.redox.2020.101589","article-title":"FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells","volume":"36","author":"H J Choi","year":"2020","journal-title":"Redox Biol"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1186\/s12967-024-05598-6","article-title":"Fatty acid oxidation is critical for the tumorigenic potential and chemoresistance of pancreatic cancer stem cells","volume":"22","author":"M Mascaraque","year":"2024","journal-title":"J Transl Med"},{"issue":"06","key":"ref69","first-page":"85","article-title":"Saturated fatty acid induces cancer stem cell-like properties in human hepatoma cells","volume":"61","author":"L W Chong","year":"2015","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"issue":"07","key":"ref70","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/abbs\/gmaa048","article-title":"Regulation and functions of the Hippo pathway in stemness and differentiation","volume":"52","author":"X Cao","year":"2020","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1367981","DOI":"10.3389\/fphar.2024.1367981","article-title":"Lipid metabolism dynamics in cancer stem cells: potential targets for cancers","volume":"15","author":"J Du","year":"2024","journal-title":"Front Pharmacol"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41420-023-01770-x","article-title":"Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation","volume":"10","author":"C Zhang","year":"2024","journal-title":"Cell Death Discov"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/s41467-026-68525-x","article-title":"Palmitic acid-triggered B7H3 palmitoylation promotes immune escape","volume":"17","author":"Z Rao","year":"2026","journal-title":"Nat Commun"},{"issue":"6468","key":"ref74","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.aaw9886","article-title":"Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice","volume":"366","author":"I M Moya","year":"2019","journal-title":"Science"},{"issue":"04","key":"ref75","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"G Sorrentino","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"09","key":"ref76","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1084\/jem.20130440","article-title":"The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils","volume":"210","author":"L Raccosta","year":"2013","journal-title":"J Exp Med"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41556-017-0009-8","article-title":"Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis","volume":"20","author":"E Ingallina","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2020.09.009","article-title":"Reduction of squalene epoxidase by cholesterol accumulation accelerates colorectal cancer progression and metastasis","volume":"160","author":"S Y Jun","year":"2021","journal-title":"Gastroenterology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.redox.2017.01.012","article-title":"Metabolic zonation of the liver: the oxygen gradient revisited","volume":"11","author":"T Kietzmann","year":"2017","journal-title":"Redox Biol"},{"issue":"04","key":"ref80","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.32408","article-title":"Liver zonation, revisited","volume":"76","author":"J Paris","year":"2022","journal-title":"Hepatology"},{"issue":"04","key":"ref81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep.28953","article-title":"Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease","volume":"65","author":"Z Hall","year":"2017","journal-title":"Hepatology"},{"issue":"S 01","key":"ref82","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/modpathol.3800680","article-title":"Pathology of fatty liver disease","volume":"20","author":"E M Brunt","year":"2007","journal-title":"Mod Pathol"},{"issue":"14","key":"ref83","first-page":"4003","article-title":"Selective implantation and growth in rats and mice of experimental liver metastasis in acinar zone one","volume":"49","author":"E Barber\u00e1-Guillem","year":"1989","journal-title":"Cancer Res"},{"issue":"08","key":"ref84","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"M Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1609752","DOI":"10.3389\/pore.2021.1609752","article-title":"An immunohistochemical study of \u03b2-catenin expression and immune cell population in metastatic carcinoma to the liver","volume":"27","author":"K Y Au","year":"2021","journal-title":"Pathol Oncol Res"},{"issue":"6784","key":"ref86","doi-asserted-by":"crossref","first-page":"eadv7129","DOI":"10.1126\/science.adv7129","article-title":"The origin of hepatocellular carcinoma depends on metabolic zonation","volume":"391","author":"J Guo","year":"2026","journal-title":"Science"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"116241","DOI":"10.1016\/j.bcp.2024.116241","article-title":"The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): an RNA sequence database analysis and review","volume":"228","author":"C Leahy","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"04","key":"ref88","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","article-title":"Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis","volume":"57","author":"M A Abdelmegeed","year":"2012","journal-title":"J Hepatol"},{"issue":"04","key":"ref89","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ijc.20282","article-title":"Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma","volume":"111","author":"J C Ho","year":"2004","journal-title":"Int J Cancer"},{"issue":"05","key":"ref90","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.7150\/thno.49368","article-title":"CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF\/MET signaling","volume":"11","author":"J Yu","year":"2021","journal-title":"Theranostics"},{"issue":"06","key":"ref91","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.21037\/jgo-23-895","article-title":"CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner","volume":"14","author":"L Jin","year":"2023","journal-title":"J Gastrointest Oncol"},{"issue":"04","key":"ref92","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/j.2040-4603.2015.tb00660.x","article-title":"Liver sinusoidal endothelial cells","volume":"5","author":"K K S\u00f8rensen","year":"2015","journal-title":"Compr Physiol"},{"issue":"06","key":"ref93","first-page":"101366","article-title":"Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment","volume":"7","author":"P E Rautou","year":"2025","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"06","key":"ref94","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s44161-024-00490-4","article-title":"Loss of fenestrae in liver sinusoidal endothelial cells contributes to MASLD","volume":"3","author":"N Ciriaci","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"02","key":"ref95","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"M Guilliams","year":"2022","journal-title":"Cell"},{"issue":"12","key":"ref96","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/s41588-025-02407-8","article-title":"Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease","volume":"57","author":"Z Li","year":"2025","journal-title":"Nat Genet"},{"issue":"11","key":"ref97","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.tem.2024.04.009","article-title":"Lipid-associated macrophages between aggravation and alleviation of metabolic diseases","volume":"35","author":"R Xu","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"7578","key":"ref98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"A Hoshino","year":"2015","journal-title":"Nature"},{"issue":"11","key":"ref99","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/carcin\/bgy115","article-title":"Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis","volume":"39","author":"Y Shao","year":"2018","journal-title":"Carcinogenesis"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","article-title":"Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis","volume":"9","author":"Z Zeng","year":"2018","journal-title":"Nat Commun"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-019-1019-x","article-title":"CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer","volume":"18","author":"J L Hu","year":"2019","journal-title":"Mol Cancer"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"154082","DOI":"10.1016\/j.phymed.2022.154082","article-title":"Jianpi Jiedu recipe inhibits colorectal cancer liver metastasis via regulating ITGBL1-rich extracellular vesicles mediated activation of cancer-associated fibroblasts","volume":"100","author":"R Li","year":"2022","journal-title":"Phytomedicine"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-025-03599-x","article-title":"A novel role of secreted methionine adenosyltransferase \u03b12 in colorectal liver metastases","volume":"45","author":"M Justo","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"issue":"05","key":"ref104","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s43587-026-01102-5","article-title":"Extracellular vesicles derived from senescent hepatocytes drive pan-cancer metastasis in aging","volume":"6","author":"H Li","year":"2026","journal-title":"Nat Aging"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"218104","DOI":"10.1016\/j.canlet.2025.218104","article-title":"Obese adipose tissue-derived extracellular vesicles enriched with glycolytic cargo promote colorectal cancer tumorigenesis","volume":"635","author":"P S Haque","year":"2025","journal-title":"Cancer Lett"},{"issue":"12","key":"ref106","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.cmet.2025.10.015","article-title":"Extracellular vesicles from obese visceral adipose promote pancreatic cancer development and resistance to immune checkpoint blockade therapy","volume":"37","author":"C Xue","year":"2025","journal-title":"Cell Metab"},{"issue":"12","key":"ref107","first-page":"e57339","article-title":"Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolism","volume":"24","author":"S Liu","year":"2023","journal-title":"EMBO Rep"},{"issue":"12","key":"ref108","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s43018-024-00862-6","article-title":"Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression","volume":"5","author":"I Wortzel","year":"2024","journal-title":"Nat Cancer"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"F Heymann","year":"2015","journal-title":"Hepatology"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/hep.30693","article-title":"NOD-like receptor C4 inflammasome regulates the growth of colon cancer liver metastasis in NAFLD","volume":"70","author":"K Ohashi","year":"2019","journal-title":"Hepatology"},{"issue":"8013","key":"ref111","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41586-024-07372-6","article-title":"Periportal macrophages protect against commensal-driven liver inflammation","volume":"629","author":"Y Miyamoto","year":"2024","journal-title":"Nature"},{"issue":"05","key":"ref112","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"T Hendrikx","year":"2022","journal-title":"J Hepatol"},{"issue":"09","key":"ref113","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41590-025-02255-y","article-title":"Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis","volume":"26","author":"O P Martin","year":"2025","journal-title":"Nat Immunol"},{"issue":"7783","key":"ref114","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"P Ramachandran","year":"2019","journal-title":"Nature"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"218657","DOI":"10.1016\/j.canlet.2026.218657","article-title":"Multi-omic profiling identifies TREM2+ lipid-laden macrophages as inflammatory drivers and therapeutic targets of colorectal cancer liver metastasis","volume":"656","author":"P X Wang","year":"2026","journal-title":"Cancer Lett"},{"issue":"09","key":"ref116","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","article-title":"Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment","volume":"34","author":"P Zhang","year":"2022","journal-title":"Cell Metab"},{"issue":"08","key":"ref117","first-page":"101488","article-title":"Myeloid TGF-\u03b2 signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis","volume":"7","author":"Z Meng","year":"2025","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"7854","key":"ref118","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"D Pfister","year":"2021","journal-title":"Nature"},{"issue":"7854","key":"ref119","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"M Dudek","year":"2021","journal-title":"Nature"},{"issue":"12","key":"ref120","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits antitumor responses","volume":"19","author":"X Michelet","year":"2018","journal-title":"Nat Immunol"},{"issue":"10","key":"ref121","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"J Leslie","year":"2022","journal-title":"Gut"},{"issue":"01","key":"ref122","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41467-025-67579-7","article-title":"Agonist signaling drives neutrophil subpopulations to promote\/inhibit colorectal cancer liver metastasis","volume":"17","author":"Z Xu","year":"2025","journal-title":"Nat Commun"},{"issue":"13","key":"ref123","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.celrep.2019.05.091","article-title":"Immature low-density neutrophils exhibit metabolic flexibility that facilitates breast cancer liver metastasis","volume":"27","author":"B E Hsu","year":"2019","journal-title":"Cell Rep"},{"issue":"02","key":"ref124","doi-asserted-by":"crossref","first-page":"115226","DOI":"10.1016\/j.celrep.2024.115226","article-title":"NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression","volume":"44","author":"W Xu","year":"2025","journal-title":"Cell Rep"},{"issue":"02","key":"ref125","doi-asserted-by":"crossref","first-page":"101351","DOI":"10.1016\/j.jcmgh.2024.04.008","article-title":"Concomitant NAFLD facilitates liver metastases and PD-1-refractory by recruiting MDSCs via CXCL5\/CXCR2 in colorectal cancer","volume":"18","author":"Y Yang","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"03","key":"ref126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/03602532.2011.577781","article-title":"Drug metabolism alterations in nonalcoholic fatty liver disease","volume":"43","author":"M D Merrell","year":"2011","journal-title":"Drug Metab Rev"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2025.11.008","article-title":"MARCO+ macrophages drive immunosuppressive remodeling and metastasis in chemotherapy-associated steatohepatitis","volume":"84","author":"K Ding","year":"2026","journal-title":"J Hepatol"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21147\/j.issn.1000-9604.2024.01.02","article-title":"Microbiota in colorectal cancer related to liver metastasis","volume":"36","author":"P Wei","year":"2024","journal-title":"Chin J Cancer Res"},{"issue":"11","key":"ref129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"S Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"issue":"08","key":"ref130","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1053\/j.gastro.2018.02.015","article-title":"P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts","volume":"154","author":"C Dou","year":"2018","journal-title":"Gastroenterology"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"217452","DOI":"10.1016\/j.canlet.2025.217452","article-title":"Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence","volume":"612","author":"Y Zhan","year":"2025","journal-title":"Cancer Lett"},{"issue":"03","key":"ref132","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/HEP.0000000000000763","article-title":"Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis","volume":"80","author":"Y Wang","year":"2024","journal-title":"Hepatology"},{"issue":"04","key":"ref133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/HC9.0000000000000669","article-title":"Depletion of tumor-reactive HSCs reveals their significance during different stages of liver metastasis","volume":"9","author":"A Benedicto","year":"2025","journal-title":"Hepatol Commun"},{"issue":"8059","key":"ref134","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41586-025-08677-w","article-title":"Hepatic stellate cells control liver zonation, size and functions via R-spondin 3","volume":"640","author":"A Sugimoto","year":"2025","journal-title":"Nature"},{"issue":"06","key":"ref135","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/gutjnl-2016-311606","article-title":"RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis","volume":"66","author":"J Hilkens","year":"2017","journal-title":"Gut"},{"issue":"7584","key":"ref136","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature16466","article-title":"Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function","volume":"529","author":"E E Storm","year":"2016","journal-title":"Nature"},{"issue":"03","key":"ref137","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","article-title":"In vivo and in vitro models to study liver fibrosis: mechanisms and limitations","volume":"16","author":"Y S Lee","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"06","key":"ref138","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"M Vacca","year":"2024","journal-title":"Nat Metab"},{"issue":"21","key":"ref139","doi-asserted-by":"crossref","first-page":"e2302436","DOI":"10.1002\/adhm.202302436","article-title":"Cancer metastasis-on-a-chip for modeling metastatic cascade and drug screening","volume":"13","author":"A Brooks","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"07","key":"ref140","first-page":"10","article-title":"Current advances and future perspectives of liver-on-a-chip platforms incorporating dynamic fluid flow","volume":"10","author":"J Yun","year":"2025","journal-title":"Biomimetics (Basel)"},{"issue":"05","key":"ref141","doi-asserted-by":"crossref","first-page":"102509","DOI":"10.1016\/j.isci.2021.102509","article-title":"Human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread","volume":"24","author":"C Strelez","year":"2021","journal-title":"iScience"},{"issue":"11","key":"ref142","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1021\/acsnano.0c04778","article-title":"Three-dimensional human liver-chip emulating premetastatic niche formation by breast cancer-derived extracellular vesicles","volume":"14","author":"J Kim","year":"2020","journal-title":"ACS Nano"},{"issue":"02","key":"ref143","doi-asserted-by":"crossref","first-page":"104611","DOI":"10.1016\/j.drudis.2026.104611","article-title":"Humanized liver mouse models in preclinical drug development: current status, translation challenges and emerging technologies","volume":"31","author":"X Zhang","year":"2026","journal-title":"Drug Discov Today"},{"issue":"03","key":"ref144","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cancers18030507","article-title":"Phase II study of pegvorhyaluronidase alfa (PEGPH20) and pembrolizumab for patients with hyaluronan-high, pretreated metastatic pancreatic ductal adenocarcinoma: PCRT16-001","volume":"18","author":"E G Chiorean","year":"2026","journal-title":"Cancers (Basel)"},{"issue":"03","key":"ref145","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ccell.2025.12.021","article-title":"Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth","volume":"44","author":"J Mateus-Tique","year":"2026","journal-title":"Cancer Cell"},{"issue":"06","key":"ref146","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"R Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"14","key":"ref147","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/foods13142280","article-title":"Protective effect of caffeine and chlorogenic acids of coffee in liver disease","volume":"13","author":"D Di Pietrantonio","year":"2024","journal-title":"Foods"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver","year":"2024","journal-title":"J Hepatol"},{"issue":"01","key":"ref149","doi-asserted-by":"crossref","first-page":"e70157","DOI":"10.1002\/edm2.70157","article-title":"Comparative analysis of glucagon receptor agonists vs. resmetirom in MASLD and MASH: network meta-analysis of clinical trials","volume":"9","author":"C R Andonie","year":"2026","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review","volume":"335","author":"H Tilg","year":"2026","journal-title":"JAMA"},{"issue":"04","key":"ref151","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","volume":"82","author":"C S Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"05","key":"ref152","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","article-title":"Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance","volume":"83","author":"M B Bansal","year":"2026","journal-title":"Hepatology"},{"issue":"21","key":"ref153","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI194743","article-title":"GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research","volume":"135","author":"E Valencia-Rinc\u00f3n","year":"2025","journal-title":"J Clin Invest"},{"issue":"04","key":"ref154","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10555-024-10192-9","article-title":"The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer","volume":"43","author":"S S Ibrahim","year":"2024","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"ref155","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1111\/cas.16331","article-title":"Cholesterol synthesis is essential for the growth of liver metastasis-prone colorectal cancer cells","volume":"115","author":"K Taniguchi","year":"2024","journal-title":"Cancer Sci"},{"issue":"13","key":"ref156","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"J N Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"issue":"13","key":"ref157","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","article-title":"Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis","volume":"19","author":"S M Robinson","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"06","key":"ref158","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/jgh.14889","article-title":"Non-alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor","volume":"35","author":"K Sawada","year":"2020","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2921-0092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:39:54Z","timestamp":1790894394000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2921-0092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":157,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2026,10,1]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2921-0092","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}